Phase I MAD Study of JNJ-55920839

Clinical Trial Grant

Duke Scholars

Principal Investigator Jennifer Lee Rogers Medicine, Rheumatology and Immunology

Administered By

Duke Clinical Research Institute

Awarded By

Janssen Pharmaceutica, Inc.

Start Date

July 11, 2017

End Date

April 30, 2019

Administered By

Duke Clinical Research Institute

Awarded By

Janssen Pharmaceutica, Inc.

Start Date

July 11, 2017

End Date

April 30, 2019